Short answer
Chemours Co (CC) filed an 8-K current report with the SEC on May 5, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Chemours reported first-quarter 2026 financial results on May 5, 2026.
Chemours Co 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Chemours reported first-quarter 2026 financial results on May 5, 2026
- Detailed results and management commentary available in Exhibit 99.1 press release
- Investor presentation scheduled by 8:00 a.m. EDT May 6, 2026, ahead of conference call
- Disclosure furnished under Regulation FD, not formally filed under Exchange Act Section 18
Item EX-99.1 · Exhibit EX-99.1
- Q1 sales $1.381B, up 1%, but net loss widened to $29M from $5M amid higher financing and SG&A costs
- Adjusted EBITDA $169M, up 2%, driven by TSS strength offsetting severe TT and APM deterioration
- TSS sales $568M, up 22%, with Adjusted EBITDA $190M and margin 33%, highlighting strong refrigerant momentum
- TT EBITDA fell 64% to $18M; APM EBITDA fell 84% to $5M, reflecting weak volumes and Washington Works outage costs
- Kuan Yin proceeds ~$287M funded €140M debt repayment; management targets net leverage below 3.8x by year-end 2026
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Chemours Co 8-K filings
Get the next CC 8-K as it lands
Follow CC for push alerts, or ask the research agent what this filing means.